Dermata Therapeutics, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 11
Rang # Quantité totale PI 139 699
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 628
Symbole boursier DRMA (nasdaq)
ISIN US2498451085
Capitalisation 2.900M  (USD)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 4
1 0
2 0
0
 
Dernier brevet 2024 - Compositions for inducing immune...
Premier brevet 2019 - Compositions and methods for the...
Dernière marque 2024 - ZYNGARI
Première marque 2015 - DERMATA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for the treatment of medical and aesthetic skin conditions and diseas...
Invention Compositions for inducing immune responses. The present disclosure is drawn to compositions, meth...
2021 Invention Compositions for the treatment of skin conditions. The present disclosure relates to the treatme...
Invention Compositions for the treatment of skin conditions. The present disclosure relates to the treatmen...
2020 Invention Compositions for the treatment of conditions by dermal fillers. The present disclosure relates t...
2019 Invention Compositions and methods for the treatment of skin conditions. Spongilla, and a second compositio...
2015 P/S Dermatological pharmaceutical products Pharmaceutical drug development services